Enforcement record

Administrative Guidance disclosure naming 医薬・生活衛生局総務課国際薬事規制室

医薬・生活衛生局総務課国際薬事規制室 (不明)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

不明Ministry of Health, Labour and WelfareGovernment disclosure

Action type

Administrative Guidance

Law

不明

Authority

Ministry of Health, Labour and Welfare

Action date

Unknown

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Source verification

Public-source and preservation status

Publishing authority
Ministry of Health, Labour and Welfare
Official source URL
Recorded by RegBase
Entity match
Not confirmed; shown under the published name
Kiroku preservation
Queued for preservation
Captured: May 2, 2026, 09:01 AM JST

“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.

Available sources and saved files are listed in the public documents section below.

Public documents and saved materials

View the original publications, see what was preserved, or download each file below.

Loading materials…

Action summary

Company
医薬・生活衛生局総務課国際薬事規制室Japanese only
Original: 医薬・生活衛生局総務課国際薬事規制室
Governing law
不明
不明
Action type
Administrative Guidance
行政指導
Action date
Unknown
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省
Industry context
行政機関

Violation

Machine-translated summary — verify against original

The Ministry of Health, Labour and Welfare's International Pharmaceutical Regulatory Affairs Office issued administrative guidance related to the 'International Pharmaceutical Regulatory Harmonization Strategy' and the 'PMDA International Strategy 2015,' aiming to support training for APEC pharmaceutical regulators and promote ICH guidelines.

Show original Japanese text

厚生労働省が策定した「国際薬事規制調和戦略」及び同日にPMDAが策定した「PMDA国際戦略2015」に資するものであり、日本がAPEC地域の薬事規制当局者に対して、当該分野の研修に中心的な役割を担うとともに、ICHガイドラインの普及などに貢献することとなります。

Compliance context

Low-medium

Administrative guidance or supervision was publicly disclosed by the authority.

Japanese regulatory disclosure under 不明.

Use as a monitoring signal. Confirm details before treating it as a formal sanction.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.